Early trials have shown a new antibody-drug conjugate may improve outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), researchers have reported.
The LOTIS-2 study investigated loncastuximab...
1 month ago
Abnormal crosstalk between blood platelets and cells lining blood vessels causes deadly organ damage in seriously ill COVID-19 patients, according to a new study.
Researchers at NYU Grossman School of Medicine, New York, USA, f...
1 month ago